169 related articles for article (PubMed ID: 26369911)
1. Use of Polyclonal Intravenous Immunoglobulin at a Paediatric Referral Hospital in South Africa Between 2009 and 2012.
Raiman S; Knight SE; Eley B; Welzel TB
J Clin Immunol; 2015 Oct; 35(7):668-74. PubMed ID: 26369911
[TBL] [Abstract][Full Text] [Related]
2. Use of non-specific intravenous human immunoglobulins in Spanish hospitals; need for a hospital protocol.
Ruiz-Antorán B; Agustí Escasany A; Vallano Ferraz A; Danés Carreras I; Riba N; Mateu Escudero S; Costa J; Sánchez Santiago MB; Laredo L; Durán Quintana JA; Castillo JR; Abad-Santos F; Payares Herrera C; Sádaba Díaz de Rada B; Gómez Ontañón E
Eur J Clin Pharmacol; 2010 Jun; 66(6):633-41. PubMed ID: 20204337
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
[TBL] [Abstract][Full Text] [Related]
4. Use of intravenous immunoglobulin in an Asian paediatric population over a 10-year period.
Wu J; Lee AJ; Goh AE; Chia M; Ho C; Bugarin JL; Shek LP; Chan YH; Lee BW
J Paediatr Child Health; 2013 Aug; 49(8):629-34. PubMed ID: 23750995
[TBL] [Abstract][Full Text] [Related]
5. Changing trends in IVIG use in pediatric patients: A retrospective review of practices in a network of major USA pediatric hospitals.
Balch A; Wilkes J; Thorell E; Pavia A; Sherwin CMT; Enioutina EY
Int Immunopharmacol; 2019 Nov; 76():105868. PubMed ID: 31487613
[TBL] [Abstract][Full Text] [Related]
6. Intravenous Immunoglobin Utilization Study in a Teaching Hospital.
Rezaie N; Shajareh E; Motamed MR; Ghanbari B; Pakdaman N; Farasatinasab M
Arch Iran Med; 2019 May; 22(5):232-235. PubMed ID: 31256594
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin utilization in a tertiary care teaching hospital in Saudi Arabia.
Alangari AA; Abutaleb MH; Albarraq AA; Al-Dhowailie AA
Saudi Med J; 2008 Jul; 29(7):975-9. PubMed ID: 18626524
[TBL] [Abstract][Full Text] [Related]
8. The role of polyclonal intravenous immunoglobulin in treating HIV-infected children with severe bacterial infections: a retrospective cohort study.
Huang LC; Myer L; Jaspan HB
BMC Infect Dis; 2008 Sep; 8():127. PubMed ID: 18811982
[TBL] [Abstract][Full Text] [Related]
9. Clinical indications for intravenous immunoglobulin utilization in a tertiary medical center: a 9-year retrospective study.
Shemer A; Kivity S; Shoenfeld Y
Transfusion; 2018 Feb; 58(2):430-438. PubMed ID: 29193136
[TBL] [Abstract][Full Text] [Related]
10. [Evolution of polyvalent intravenous immunoglobulins (IVIg) prescription, at the Assistance Publique - Hopitaux de Paris between 1988 and 1997. Results of the plan of action set up in order to regulate the prescription].
Courtay A; Couturon I; Charpentier E; Viens-Bitker C; Guillevin L; Etienne JP; Fery-Lemonnier E
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S5-12. PubMed ID: 10896982
[TBL] [Abstract][Full Text] [Related]
11. A multicenter drug use surveillance of intravenous immunoglobulin utilization in US academic health centers.
Chen C; Danekas LH; Ratko TA; Vlasses PH; Matuszewski KA
Ann Pharmacother; 2000 Mar; 34(3):295-9. PubMed ID: 10917372
[TBL] [Abstract][Full Text] [Related]
12. How intravenous immunoglobulin is used in clinical practice: audits of two Sydney teaching hospitals.
Lin MW; Kirkpatrick PE; Riminton DS
Intern Med J; 2007 May; 37(5):308-14. PubMed ID: 17504278
[TBL] [Abstract][Full Text] [Related]
13. [IgIV at home:experience of a center--economic aspects].
Hachulla E
Rev Med Interne; 2007 May; 28 Spec No. 1():7-10. PubMed ID: 17768832
[TBL] [Abstract][Full Text] [Related]
14. Use of intravenous immunoglobulins in clinical practice: data from three French university hospitals.
Frauger E; Grassi J; Pradel V; Bornet C; Rouby F; Delorme J; Ousset S; Braguer D; Azulay JP; Penot-Ragon C; Harle JR; Bongrand MC; Weiller PJ; Pouget J; Michel G; Micallef J; Reynier JP; Tardieu S; Vanelle P; Blin O;
Fundam Clin Pharmacol; 2011 Dec; 25(6):753-61. PubMed ID: 21219439
[TBL] [Abstract][Full Text] [Related]
15. Changes in intravenous immunoglobulin prescribing patterns during a period of severe product shortages, 1995-2000.
Pendergrast JM; Sher GD; Callum JL
Vox Sang; 2005 Oct; 89(3):150-60. PubMed ID: 16146507
[TBL] [Abstract][Full Text] [Related]
16. Inpatient paediatric use of intravenous immunoglobulin at an academic medical centre.
Dashti-Khavidaki S; Khalili H; Farshadi F; Aghamohammadi A; Movahedi M; Hajibabaei M
Singapore Med J; 2008 Feb; 49(2):147-9. PubMed ID: 18301844
[TBL] [Abstract][Full Text] [Related]
17. Intravenous Immune Globulin Stewardship Program at a Tertiary Academic Medical Center.
Rocchio MA; Schurr JW; Hussey AP; Szumita PM
Ann Pharmacother; 2017 Feb; 51(2):135-139. PubMed ID: 27758967
[TBL] [Abstract][Full Text] [Related]
18. Variability in intravenous immunoglobulin G regimens for autoimmune neuromuscular disorders.
Broyles R; Rodden L; Riley P; Berger M
Postgrad Med; 2013 Mar; 125(2):65-72. PubMed ID: 23816772
[TBL] [Abstract][Full Text] [Related]
19. Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.
Zhou Z; Qiao Z; Li H; Luo N; Zhang X; Xue F; Yang R
Autoimmunity; 2016; 49(1):50-7. PubMed ID: 26525513
[TBL] [Abstract][Full Text] [Related]
20. The use of intravenous immunoglobulin therapy in a tertiary pediatric hospital.
Güngör A; Yarali N
Saudi Med J; 2020 Feb; 41(2):163-167. PubMed ID: 32020150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
